ACTRN12621001494820已完成未知
Delta-Max: An Observational study targeting maximal EEG Delta wave activity during general anaesthesia
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •Adult patients (18-90years) presenting for routine surgery under general anaesthesia
排除标准
- •Operations on head that would preclude placement of EEG.
- •Inability to give informed study consent for any reason
- •Moribund patients not expected to survive 24 hours, or those needing planned postoperative ICU admission.
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate the safety, antitumour activity and determine the maximum tolerated dose of Debio 1143 combined with Chemo-Radiation Therapy in patients with advanced head and neck cancer.Patients with locally advanced squamous cell carcinoma of the head and neckMedDRA version: 14.1Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000044-25-FRDebiopharm S.A.116
进行中（未招募）
1 期
Dose-escalating study to determine the maximum tolerated dose (MTD) of the mistletoe extract WEME 200 mg for intravesical instillation in patients with completely resected (R0) superficial bladder carcinoma (pTa low grade [multilocular or recurrence], pT1 low grade)C67Malignant neoplasm of bladderDRKS00002070WELEDA AG4
进行中（未招募）
不适用
Dose-escalating study to determine the maximum tolerated dose (MTD) of the mistletoe extract WEME 200 mg for intravesical instillation in patients with completely resected (R0) superficial bladder carcinoma (pTa low grade [multilocular or recurrence], pT1 low grade) - Intravesical instillation of mistletoe extract (WEME 200 mg) in superficial bladder carcinomaPatients after transurethral R0-resection (TUR) of a histologically confirmed superficial bladder carcinoma (pTa low grade [multilocular or recurrence], pT1 low grade)re-resections included.MedDRA version: 9.1Level: LLTClassification code 10046518Term: Urinary bladder carcinomaEUCTR2008-000782-35-DEVerein fuer Krebsfoschung (Society for Cancer Research)
招募中
不适用
Study to evaluate factors associated with maximum mouth opening in patients with squamous cell carcinoma. of oral cavity and oropharynxCTRI/2011/11/002106Tata Memorial Hospital120
已完成
不适用
Prospective Observational Study for the Optimal Initiation of Dialysis treatmentEnd-stage renal diseaseJPRN-UMIN000039224Juntendo University Faculity of Medicine400